Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-082970
Filing Date
2025-06-06
Accepted
2025-06-06 15:06:46
Documents
1
Period of Report
2025-06-05

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 4034
  Complete submission text file 0000950170-25-082970.txt   5492
Mailing Address C/O AKERO THERAPEUTICS, INC. 170 HARBOR WAY 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address
White William Richard (Reporting) CIK: 0001778739 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40928 | Film No.: 251030184

Mailing Address 12790 EL CAMINO REAL, SUITE 200 SAN DIEGO CA 92130
Business Address 12790 EL CAMINO REAL, SUITE 200 SAN DIEGO CA 92130 (858) 945-2393
Ventyx Biosciences, Inc. (Issuer) CIK: 0001851194 (see all company filings)

EIN.: 832996852 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)